Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rani Therapeutics Holdings (RANI) Total Current Liabilities (2020 - 2025)

Historic Total Current Liabilities for Rani Therapeutics Holdings (RANI) over the last 6 years, with Q3 2025 value amounting to $19.1 million.

  • Rani Therapeutics Holdings' Total Current Liabilities fell 527.93% to $19.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.1 million, marking a year-over-year decrease of 527.93%. This contributed to the annual value of $19.9 million for FY2024, which is 14897.98% up from last year.
  • Latest data reveals that Rani Therapeutics Holdings reported Total Current Liabilities of $19.1 million as of Q3 2025, which was down 527.93% from $20.6 million recorded in Q2 2025.
  • Rani Therapeutics Holdings' 5-year Total Current Liabilities high stood at $20.6 million for Q2 2025, and its period low was $2.6 million during Q4 2021.
  • Over the past 5 years, Rani Therapeutics Holdings' median Total Current Liabilities value was $7.7 million (recorded in 2023), while the average stood at $10.8 million.
  • Per our database at Business Quant, Rani Therapeutics Holdings' Total Current Liabilities tumbled by 5026.38% in 2021 and then surged by 18911.94% in 2024.
  • Rani Therapeutics Holdings' Total Current Liabilities (Quarter) stood at $2.6 million in 2021, then skyrocketed by 82.39% to $4.8 million in 2022, then surged by 65.92% to $8.0 million in 2023, then skyrocketed by 148.98% to $19.9 million in 2024, then dropped by 3.76% to $19.1 million in 2025.
  • Its Total Current Liabilities was $19.1 million in Q3 2025, compared to $20.6 million in Q2 2025 and $20.1 million in Q1 2025.